原发性开角型青光眼患者决策辅助方案的构建及应用
作者:
作者单位:

作者简介:

女,本科,主管护师

通讯作者:

基金项目:

重庆市社会科学规划项目(2018QNSH42);陆军军医大学苗圃人才培养项目(XZ-2019-505-054)


Construction and application of a patient decision aid for persons having primary open-angle glaucoma
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 探讨决策辅助方案在原发性开角型青光眼患者中的应用效果。方法 将100例原发性开角型青光眼患者按住院时间分为对照组与观察组各50例;对照组行常规护理,观察组在常规护理基础上实施决策辅助方案。分别于干预后(出院前)、出院后1、3个月评价干预效果。结果 干预后观察组决策困境得分显著低于对照组,决策准备得分显著高于对照组,出院后1、3个月药物依从性得分显著高于对照组,出院后3个月目标眼压达标率显著高于对照组(均P<0.05)。结论 决策辅助方案的应用可有效降低原发性开角型青光眼患者决策困境水平,提高决策准备度,增强用药依从性,从而提高目标眼压达标率。

    Abstract:

    Objective To investigate the effect of a patient decision aid applied in persons having primary open-angle glaucoma (POAG). Methods One hundred POAG patients were chronologically assigned to two groups, with 50 in each. The control group was given routine nursing care, while the observation group additionally received decision-making assistance. The effects were measured immediately post intervention (before discharge) and at 1 and 3 months post discharge. Results The observation group had significantly lower score of decisional conflict but higher score of preparation for decision-making compared with the control group after the intervention (both P<0.05). The scores of medication adherence at 1 and 3 months post discharge, as well as the achieving rate of target intraocular pressure at 3 months post discharge were significantly higher in the observation group than those in the control group (all P<0.05). Conclusion The patient decision aid formulated in this study can effectively reduce decisional conflict of patients, improve their preparation for decision-making, enhance medication adherence, and increase the achieving rate of target intraocular pressure.

    参考文献
    相似文献
    引证文献
引用本文

王露,万君丽,郭文梅,张凤,卞薇.原发性开角型青光眼患者决策辅助方案的构建及应用[J].护理学杂志,2023,28(12):5-9

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2023-01-30
  • 最后修改日期:2023-03-01
  • 录用日期:
  • 在线发布日期: 2023-12-29